PNN Mumbai (Maharashtra) [India], October 4: Amanta Healthcare Limited (Amanta, The Company) engaged in the development, manufacturing, and marketing of a diverse range of sterile liquid products, has filed its Draft Red Herring Prospectus with NSE & BSE in preparation for the IPO, The issue size will be of up to 1,25,00,000 equity shares with a face value of Rs 10 each, all of which will be issued as a Fresh Issue. Also Read | Kamlesh Singh Joins BJP: Jharkhand's Lone NCP MLA Joins Saffron Party Ahead of Upcoming Assembly Elections (Watch Video). Amanta's objective is to raise funds for capital expenditure requirements for civil construction work and towards purchase of equipment, plant and machinery for setting up new manufacturing line for SteriPort at Hariyala, Kheda, Gujarat.
It also aims to secure funding for capital expenditure requirements towards purchase of equipment, plant and machinery for setting up a new Small Volume Parenteral (SVP) manufacturing line at the same location and general corporate purposes. For the period ended 31st March 2024, The company reported Revenue of Rs 28,034.03 Lakhs and EBITDA of Rs 5,875.
65 Lakhs & PAT of Rs 363.32 Lakhs. Also Read | BMW Group India Posts 'Best-Ever Luxury Car Sales' with 10% Growth in Country in January-September Period, Sells 10,556 Units.
About Amanta Healthcare Limited Amanta Healthcare Limited is a pharmaceutical company specializing in the development, manufacturing, and marketing of sterile liquid products. Usin.
